Scientists test drug duo in battle against tough head & neck cancers
NCT ID NCT03370276
Summary
This study tested whether combining two existing cancer drugs, cetuximab and nivolumab, could help people with advanced head and neck cancer that had returned or spread. The first part aimed to find the safest dose of the combination. The second part aimed to see if this combination helped patients live longer. It involved 95 adults whose cancer had progressed despite prior treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University School of Medicine
Atlanta, Georgia, 30322, United States
-
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
-
The Ohio State University
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.